StockData
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31

Satellos Bioscience Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026
$6.44−0.02 (-0.31%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

29 of Satellos Bioscience's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report6-KOct 21, 2026Oct 21, 2026SEC EDGAR
Current report6-KOct 5, 2026Oct 5, 2026SEC EDGAR
Current report6-KSep 30, 2026Sep 30, 2026SEC EDGAR
Current report6-KSep 24, 2026Sep 24, 2026SEC EDGAR
Current report6-KSep 15, 2026Sep 15, 2026SEC EDGAR
Current report6-KSep 9, 2026Sep 9, 2026SEC EDGAR
Current report6-KSep 1, 2026Sep 1, 2026SEC EDGAR
Current report6-KAug 14, 2026Aug 14, 2026SEC EDGAR
Current report6-KJun 30, 2026Aug 13, 2026SEC EDGAR
Current report6-KJul 8, 2026Jul 8, 2026SEC EDGAR
Current report6-KJun 29, 2026Jun 29, 2026SEC EDGAR
Current report6-KJun 25, 2026Jun 25, 2026SEC EDGAR
Current report6-KJun 17, 2026Jun 18, 2026SEC EDGAR
Current report6-KJun 17, 2026Jun 17, 2026SEC EDGAR
Current report6-KMay 27, 2026May 27, 2026SEC EDGAR
Current report6-KMay 19, 2026May 20, 2026SEC EDGAR
Current report6-KMar 31, 2026May 15, 2026SEC EDGAR
Current report6-KApr 9, 2026Apr 9, 2026SEC EDGAR
Current report6-KMar 27, 2026Mar 27, 2026SEC EDGAR
Annual report40-FDec 31, 2025Mar 27, 2026SEC EDGAR
Current report6-KMar 10, 2026Mar 10, 2026SEC EDGAR
Current report6-KFeb 24, 2026Feb 24, 2026SEC EDGAR
Current report6-KFeb 19, 2026Feb 19, 2026SEC EDGAR
Current report6-KFeb 18, 2026Feb 18, 2026SEC EDGAR
Current report6-KFeb 17, 2026Feb 17, 2026SEC EDGAR
Current report6-KFeb 10, 2026Feb 12, 2026SEC EDGAR
Current report6-KFeb 10, 2026Feb 10, 2026SEC EDGAR
Current report6-KFeb 9, 2026Feb 10, 2026SEC EDGAR
Current report6-KFeb 6, 2026Feb 6, 2026SEC EDGAR